New Diagnostic Markers In Dignosis Of Complicated Appendix

Sponsor
Sohag University (Other)
Overall Status
Recruiting
CT.gov ID
NCT06102239
Collaborator
(none)
50
1
6
8.4

Study Details

Study Description

Brief Summary

Most common cause of acute abdomen is acute appendicitis delay dignosis of acute appendicitis lead to complications as perforation this study examined efficacy of hyperbilirubinemia&hyponatremia as indicator of complicated appendicitis

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Bilirubin level sodium level c reactive protein level
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
New Diagnostic Markers In Dignosis Of Complicated Appendix
Actual Study Start Date :
Oct 1, 2023
Anticipated Primary Completion Date :
Mar 31, 2024
Anticipated Study Completion Date :
Mar 31, 2024

Outcome Measures

Primary Outcome Measures

  1. Level of bilirubin in acute appendicitis [6 months]

  2. Level of sodium in acute appendicitis [6 months]

  3. Level of c-reactive proteins in acute appendicitis [6 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
10 Years to 40 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • all patient admitted for acute appendicitis underwent surgery and post operativly confirmed histopathology of acute appendicitis
Exclusion Criteria:
  • patient with liver disease Liver transplantation Chronic alcoholism Congental biliary disease Pregnancy Appendicular neoplasm Hemolytic disease Hepatocellular carcinoma

Contacts and Locations

Locations

Site City State Country Postal Code
1 Sohag University hospital Sohag Egypt

Sponsors and Collaborators

  • Sohag University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Amr Mohamed Amin, Residiant in general surgery department, Sohag University
ClinicalTrials.gov Identifier:
NCT06102239
Other Study ID Numbers:
  • Soh-Med-23-09-08Ms
First Posted:
Oct 26, 2023
Last Update Posted:
Oct 26, 2023
Last Verified:
Oct 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 26, 2023